1. Home
  2. CARS vs ANL Comparison

CARS vs ANL Comparison

Compare CARS & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cars.com Inc.

CARS

Cars.com Inc.

HOLD

Current Price

$11.81

Market Cap

659.5M

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$14.16

Market Cap

611.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CARS
ANL
Founded
1998
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Motor Vehicles
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
659.5M
611.1M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
CARS
ANL
Price
$11.81
$14.16
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$16.00
$20.00
AVG Volume (30 Days)
661.3K
160.4K
Earning Date
05-07-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.33
N/A
Revenue
$723,239,000.00
N/A
Revenue This Year
$3.03
$36.02
Revenue Next Year
$2.57
N/A
P/E Ratio
$35.97
N/A
Revenue Growth
0.57
N/A
52 Week Low
$7.40
$0.88
52 Week High
$13.97
$17.25

Technical Indicators

Market Signals
Indicator
CARS
ANL
Relative Strength Index (RSI) 50.39 64.64
Support Level $11.77 $8.96
Resistance Level $12.16 $15.32
Average True Range (ATR) 0.66 1.06
MACD -0.07 0.01
Stochastic Oscillator 45.82 82.18

Price Performance

Historical Comparison
CARS
ANL

About CARS Cars.com Inc.

Cars.com Inc is an audience-powered and data-driven technology platform that simplifies buying and selling cars. The flagship Cars.com marketplace connects consumers to dealerships across the U.S., powering the car-buying experience with artificial intelligence (AI) shopping tools, vehicle reviews and content. Its ecosystem of products enables dealers and OEMs to sell more cars by leveraging the marketplace, dealer websites, trade and appraisal tools and proprietary in-market media solutions. The platform provides shoppers with data, resources and digital tools to make informed buying decisions and connect with automotive retailers. The Company also provides dealerships and OEMs with solutions and data-driven intelligence to reach and influence its 26 million monthly shoppers.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

Share on Social Networks: